382 related articles for article (PubMed ID: 27250919)
1. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
[TBL] [Abstract][Full Text] [Related]
2. Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.
Diaconu D; Antoci V; Mangalagiu V; Amariucai-Mantu D; Mangalagiu II
Sci Rep; 2022 Oct; 12(1):16988. PubMed ID: 36216981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.
Al Matarneh CM; Mangalagiu II; Shova S; Danac R
J Enzyme Inhib Med Chem; 2016; 31(3):470-80. PubMed ID: 25945747
[TBL] [Abstract][Full Text] [Related]
4. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
Rachakonda V; Alla M; Kotipalli SS; Ummani R
Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
[TBL] [Abstract][Full Text] [Related]
5.
Antoci V; Cucu D; Zbancioc G; Moldoveanu C; Mangalagiu V; Amariucai-Mantu D; Aricu A; Mangalagiu II
Future Med Chem; 2020 Feb; 12(3):207-222. PubMed ID: 31916456
[No Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
El-Gohary NS; Shaaban MI
Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654
[TBL] [Abstract][Full Text] [Related]
7. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Sirim MM; Krishna VS; Sriram D; Unsal Tan O
Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
[TBL] [Abstract][Full Text] [Related]
8. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
11. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives.
Polkam N; Rayam P; Anireddy JS; Yennam S; Anantaraju HS; Dharmarajan S; Perumal Y; Kotapalli SS; Ummanni R; Balasubramanian S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1398-402. PubMed ID: 25765907
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
16. Quinoline and quinolones: promising scaffolds for future antimycobacterial agents.
Singh S; Kaur G; Mangla V; Gupta MK
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):492-504. PubMed ID: 25032745
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents.
Rao YJ; Sowjanya T; Thirupathi G; Murthy NYS; Kotapalli SS
Mol Divers; 2018 Nov; 22(4):803-814. PubMed ID: 29869169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
